IMNM — Recent News Coverage
All news mentioning IMNM in ESEN's AI-graded feed
News stories with IMNM as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on IMNM. See /coverage/IMNM for the 30-day aggregate.
SEEKINGALPHA.COM
·
2026-11-17
LOW
BULLISH
CORR0.45
Immunome: De-Risked With The FDA, With An Admirably Deep Clinical Bench
$IMNM
◈ ESEN AI
Immunome (IMNM) is characterized as a de-risked clinical-stage biotech with meaningful FDA validation and a comparatively attractive valuation relative to recent peer M&A precedent. The analyst's constructive stance ref…
SEEKINGALPHA.COM
·
2026-08-13
NEUTRAL
BULLISH
CORR0.42
Immunome: Maintaining My 'Strong Buy' Rating With 2 Catalysts On The Horizon (IMNM)
$IMNM
◈ ESEN AI
This article represents a scheduled analyst commentary on IMNM's pipeline progress rather than a market-moving catalyst announcement. The FDA's acceptance of the varegacestat NDA is a procedural milestone—a predictable …
EXPLORE OTHER FILTERS